Bausch + Lomb Corporation (NYSE: BLCO)

This investigation is for anyone who acquired securities in Bausch + Lomb Corporation (NYSE: BLCO) prior to April 30, 2025.

The Law Offices of Howard G. Smith believes that the Company and certain of its executives violated federal law. Specifically, the Law Offices of Howard G. Smith believes that the Company misled investors regarding its financial condition. More specifically, the Law Offices of Howard G. Smith believes that the Company misled investors by failing to timely disclose to investors that Company would be recalling its enVista® intraocular lenses.

On March 27, 2025, BLCO disclosed that it had “[begun] to see an increased number of reports of toxic anterior segment syndrome (TASS) in conjunction with enVista® intraocular lenses (IOLs)” and was voluntarily recalling all of its enVista Envy and enVista Aspire IOLs, as well as enVista monofocal lenses. On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume. Then, on April 30, 2025, BLCO released its first quarter 2025 financial results, disclosing that “as enVista ramps back up, for the full year 2025, [it] estimate[s] one-time recall headwinds of approximately $55 million to revenue and $65 million to adjusted EBITDA.” On this news, the price of the Company’s stock again dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Bausch + Lomb Corporation (NYSE: BLCO) prior to April 30, 2025 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.